東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/06/15 | 2,265 | 2,269 | 2,225 | 2,240 | -1 | ±0% | 133,400 |
2022/06/14 | 2,271 | 2,278 | 2,218 | 2,241 | -180 | -7.4% | 273,400 |
2022/06/13 | 2,405 | 2,431 | 2,394 | 2,421 | -20 | -0.8% | 77,400 |
2022/06/10 | 2,450 | 2,456 | 2,429 | 2,441 | -32 | -1.3% | 78,600 |
2022/06/09 | 2,500 | 2,500 | 2,466 | 2,473 | -36 | -1.4% | 81,000 |
2022/06/08 | 2,481 | 2,520 | 2,480 | 2,509 | +25 | +1% | 69,700 |
2022/06/07 | 2,465 | 2,489 | 2,455 | 2,484 | +32 | +1.3% | 81,800 |
2022/06/06 | 2,449 | 2,479 | 2,448 | 2,452 | +14 | +0.6% | 87,100 |
2022/06/03 | 2,430 | 2,453 | 2,423 | 2,438 | +14 | +0.6% | 78,700 |
2022/06/02 | 2,432 | 2,432 | 2,403 | 2,424 | -8 | -0.3% | 55,700 |
2022/06/01 | 2,399 | 2,443 | 2,399 | 2,432 | +35 | +1.5% | 64,900 |
2022/05/31 | 2,427 | 2,445 | 2,397 | 2,397 | -80 | -3.2% | 113,600 |
2022/05/30 | 2,431 | 2,498 | 2,411 | 2,477 | +75 | +3.1% | 165,500 |
2022/05/27 | 2,396 | 2,402 | 2,360 | 2,402 | +32 | +1.4% | 61,100 |
2022/05/26 | 2,370 | 2,398 | 2,370 | 2,370 | -2 | -0.1% | 46,500 |
2022/05/25 | 2,420 | 2,432 | 2,372 | 2,372 | -35 | -1.5% | 72,600 |
2022/05/24 | 2,449 | 2,454 | 2,405 | 2,407 | -67 | -2.7% | 76,700 |
2022/05/23 | 2,483 | 2,490 | 2,448 | 2,474 | +41 | +1.7% | 90,700 |
2022/05/20 | 2,452 | 2,460 | 2,411 | 2,433 | -27 | -1.1% | 99,500 |
2022/05/19 | 2,449 | 2,471 | 2,411 | 2,460 | -12 | -0.5% | 81,400 |
2022/05/18 | 2,501 | 2,520 | 2,470 | 2,472 | -46 | -1.8% | 126,200 |
2022/05/17 | 2,516 | 2,596 | 2,511 | 2,518 | +52 | +2.1% | 152,500 |
2022/05/16 | 2,610 | 2,622 | 2,465 | 2,466 | -277 | -10.1% | 204,700 |
2022/05/13 | 2,680 | 2,780 | 2,680 | 2,743 | +26 | +1% | 70,800 |
2022/05/12 | 2,713 | 2,763 | 2,704 | 2,717 | +2 | +0.1% | 66,700 |
2022/05/11 | 2,705 | 2,732 | 2,681 | 2,715 | -41 | -1.5% | 89,100 |
2022/05/10 | 2,840 | 2,840 | 2,747 | 2,756 | -104 | -3.6% | 94,700 |
2022/05/09 | 2,878 | 2,897 | 2,849 | 2,860 | -5 | -0.2% | 69,200 |
2022/05/06 | 2,815 | 2,875 | 2,797 | 2,865 | +23 | +0.8% | 79,600 |
2022/05/02 | 2,764 | 2,855 | 2,760 | 2,842 | +84 | +3% | 95,100 |
2022/04/28 | 2,643 | 2,763 | 2,626 | 2,758 | +145 | +5.5% | 71,800 |
2022/04/27 | 2,578 | 2,650 | 2,577 | 2,613 | -2 | -0.1% | 144,100 |
2022/04/26 | 2,616 | 2,623 | 2,602 | 2,615 | -15 | -0.6% | 45,300 |
2022/04/25 | 2,634 | 2,644 | 2,616 | 2,630 | -32 | -1.2% | 51,400 |
2022/04/22 | 2,649 | 2,672 | 2,632 | 2,662 | -4 | -0.2% | 43,900 |
2022/04/21 | 2,649 | 2,677 | 2,649 | 2,666 | +21 | +0.8% | 56,100 |
2022/04/20 | 2,620 | 2,659 | 2,608 | 2,645 | +51 | +2% | 53,500 |
2022/04/19 | 2,595 | 2,635 | 2,588 | 2,594 | +14 | +0.5% | 58,200 |
2022/04/18 | 2,620 | 2,634 | 2,555 | 2,580 | -72 | -2.7% | 63,900 |
2022/04/15 | 2,651 | 2,679 | 2,617 | 2,652 | -15 | -0.6% | 57,500 |
2022/04/14 | 2,629 | 2,679 | 2,616 | 2,667 | +8 | +0.3% | 29,300 |
2022/04/13 | 2,629 | 2,665 | 2,611 | 2,659 | +30 | +1.1% | 47,400 |
2022/04/12 | 2,685 | 2,685 | 2,617 | 2,629 | -77 | -2.8% | 57,100 |
2022/04/11 | 2,659 | 2,712 | 2,654 | 2,706 | +66 | +2.5% | 56,400 |
2022/04/08 | 2,691 | 2,700 | 2,631 | 2,640 | -22 | -0.8% | 59,000 |
2022/04/07 | 2,687 | 2,687 | 2,627 | 2,662 | -29 | -1.1% | 78,600 |
2022/04/06 | 2,744 | 2,770 | 2,691 | 2,691 | -26 | -1% | 66,000 |
2022/04/05 | 2,750 | 2,770 | 2,705 | 2,717 | -10 | -0.4% | 87,400 |
2022/04/04 | 2,717 | 2,740 | 2,700 | 2,727 | -27 | -1% | 85,900 |
2022/04/01 | 2,734 | 2,770 | 2,700 | 2,754 | +6 | +0.2% | 53,100 |
601~
650
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム